SCHEMBL4351314

SCHEMBL4351314

Cc1ccc(/C=C2\SC(NC(=O)Nc3ccccc3C(F)(F)F)=NC2=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
TSHR P16473 1/20 0.47
ALOX5 P09917 7/20 0.43
LMNA P02545 2/20 0.43
MAPT P10636 2/20 0.43
ALOX12 P18054 1/20 0.43
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
TP53 P04637 1/20 0.42
POLB P06746 2/20 0.41
MAPK1 P28482 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPC1 O15118 1/20 0.40
THRB P10828 1/20 0.40
RAB9A P51151 1/20 0.40
NOX1 Q9Y5S8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4351318 1.00 ALDH1A1 (0.47) ALDH1A1TSHRALOX5LMNAMAPT
SCHEMBL4351701 0.91 MEN1 (0.43) ALDH1A1TSHRALOX5LMNAMAPT
SCHEMBL4351703 0.91 MEN1 (0.43) ALDH1A1TSHRALOX5LMNAMAPT
SCHEMBL4352759 0.81 EPHX2 (0.47) ALDH1A1ALOX5LMNAMAPTKDM4E
SCHEMBL4352758 0.81 EPHX2 (0.47) ALDH1A1ALOX5LMNAMAPTKDM4E
SCHEMBL4346307 0.80 NPC1 (0.43) ALDH1A1TSHRALOX5MAPTKDM4E
SCHEMBL4352766 0.78 ALOX5 (0.43) ALDH1A1ALOX5LMNAMAPTKDM4E
SCHEMBL4351322 0.78 ALOX5 (0.45) ALDH1A1ALOX5LMNAMAPTKDM4E
SCHEMBL4352670 0.75 EPHX2 (0.52) ALDH1A1ALOX5LMNAMAPTKDM4E
SCHEMBL4352665 0.75 EPHX2 (0.52) ALDH1A1ALOX5LMNAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 ALDH1A1 284/4885TSHR 331/4885ALOX5 2623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.